Phase II trial of famotidine/omeprazole in patients with gastro-oesophageal reflux disease.

Trial Profile

Phase II trial of famotidine/omeprazole in patients with gastro-oesophageal reflux disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Oct 2008

At a glance

  • Drugs Famotidine/omeprazole (Primary) ; Famotidine; Omeprazole
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Sponsors Orexo
  • Most Recent Events

    • 03 Apr 2008 New trial record.
    • 27 Mar 2008 Results have been reported in an Orexo media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top